Micron Starts 1α DDR4; Tilray Launches CBD Oral Solution
Micron began first production of 1α DDR4 in Virginia, while Tilray launched a prescription CBD oral solution in Panama.
Micron Technology Inc (MU) launched first production starts of its 1α (1-alpha) DDR4 technology in its Manassas, Virginia, fab in 2026, a step the company said will add capability to support legacy product needs of customers in auto, industrial, medical, aerospace and defense markets.
The memory maker also broke ground on its first New York fab in January 2026 and, in July 2026, achieved the first concrete pour for that fab’s foundation, marking the transition from site preparation into vertical construction. It expects initial wafer output in calendar 2030 and said the planned Clay, New York, site of up to four fabs over the next 20-plus years is expected to be key to additional wafer capacity.
Tilray Brands, Inc. (TLRY) commercially launched Tilray Oral Solution CBD100 in Panama in July 2026, manufactured at EU-GMP-certified facilities in Portugal and supplied through joint venture Solana Life Group. Tilray said the product is intended to be distributed by prescription through Farmacias Arrocha, expanding patient access to regulated, pharmaceutical-quality cannabinoid medicine through established healthcare channels.
Tilray also listed recent Breckenridge Distillery launches, including Mock One, a non-alcoholic spirits line, Mountain Shot, flavored whiskey in convenient pouches, and Casa Breck Tequila, with Breckenridge products available in all 50 states.
Treasure Global Inc (TGL) said its ZCITY App, an online-to-offline e-commerce platform offering instant rebates and affiliate cashback, was successfully launched in Malaysia in June 2020 and remains available there. As of October 13, 2026, the company reported 2,715,386 registered users and 2,027 registered merchants.